This 2017 study examines the market penetration of non-quality-assured artemisinin combination therapy (ACT) across eight African countries to assess quality.
Other
Publication Date:
2017
This 2017 study examines the market penetration of non-quality-assured artemisinin combination therapy (ACT) across eight African countries to assess quality.
Share Article
Browse the full Publication Library — filter by impact area, resource type, year and collection to find what you need.